MicroRNA expression profiles in non‑epithelial ovarian tumors

Roger K Chang1, Xidan Li2, Ninni Mu1

  • 1Department of Oncology-Pathology, Karolinska Institutet, Cancer Center Karolinska, Karolinska University Hospital, SE-171 76 Stockholm, Sweden.

Insights

This study investigated microRNA (miRNA) expression in rare ovarian germ cell tumors (OGCTs) and sex cord stromal tumors (SCSTs). Specific miRNA profiles, like higher miR-373-3p in malignant OGCTs, may serve as ovarian cancer biomarkers.

Area of Science:

  • Gynecologic Oncology
  • Molecular Pathology
  • Genomics

Background:

  • Ovarian germ cell tumors (OGCTs) and sex cord stromal tumors (SCSTs) are rare gynecologic neoplasms.
  • Their molecular pathogenesis remains poorly understood compared to epithelial ovarian cancers.

Purpose of the Study:

  • To characterize microRNA (miRNA) expression profiles in OGCTs and SCSTs.
  • To identify potential miRNA biomarkers for distinguishing tumor types and malignancy.

Main Methods:

  • Small RNA sequencing was used to analyze miRNA expression in 9 OGCTs and 3 SCSTs.
  • Quantitative reverse transcription PCR validated miRNA expression in an extended cohort (16 OGCTs, 7 SCSTs).
  • Western blot analysis assessed Beclin 1 (BECN1) expression in relation to miRNA levels.

Main Results:

  • Significant miRNA expression variations were observed across OGCTs and SCSTs.
  • Malignant OGCTs showed higher expression of miR-373-3p, miR-372-3p, miR-302c-3p and lower expression of miR-199a-5p, miR-214-5p, miR-202-3p compared to benign OGCTs or SCSTs.
  • SCSTs exhibited higher miR-202c-3p and miR-513c-5p than benign OGCTs. BECN1 expression was elevated in malignant OGCTs, inversely correlating with miR-199a-5p levels.

Conclusions:

  • Specific miRNA signatures differentiate OGCTs and SCSTs, and correlate with malignancy in OGCTs.
  • These miRNAs hold potential as diagnostic biomarkers for ovarian tumors.
  • The findings offer insights into the molecular mechanisms underlying OGCT and SCST development.